Humatica achieves record growth in 2021

ndetails

2021 was another successful year of growth for Humatica as funds increasingly embrace organizational effectiveness as a lever for value creation. With 19% revenue growth, we added six new fund clients in the US/EU during the year, and were recognized as one of the Top 100 private firms in Europe by Red Herring.

Humatica infographic 2021
Click on the image for larger view

We look forward to continued growth in 2022 with a doubling of our investments in tools, methods and a footprint expansion. Humatica takes this opportunity to thank our loyal clients for their continued trust.

To download the Humatica 2021 infographic as PDF, please click here.

Related News

Humatica announces senior promotions in London and Zurich
01 Apr., 2026 By Humatica

Humatica announces senior promotions in London and Zurich

Humatica is pleased to announce two senior level promotions, reflecting continued growth and the strengthening of its leadership team. Paul Simpson, based in Zurich, has…

Read more arrowicon
Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards
27 Jan., 2026 By Humatica

Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards

Humatica has once again been short-listed for Actum’s 2026 Value Creation Award in the People & Organisational Strategy category. This recognition reflects Humatica’s 23‑year commitment…

Read more arrowicon
Humatica is again finalist for prestigious Real Deals Award
16 Jan., 2026 By Humatica

Humatica is again finalist for prestigious Real Deals Award

Humatica is once again shortlisted for Real Deals’ prestigious Private Equity Awards 2026 in the “Value Creation Adviser of the Year” category. This recognition underscores…

Read more arrowicon